Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Availability of an ultra-short-course drug regimen capable of curing patients with tuberculosis in 2 to 3 mo would significantly improve global control efforts. Because immediate prospects for novel treatment-shortening drugs remain uncertain, we examined whether better use of existing drugs could s...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-12-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2140085?pdf=render |